Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis DOI

Rahul D. Jana,

Hieu D. Nguyen,

Guangjie Yan

et al.

Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 3, 2025

We report the application of organoiridium complexes as catalytic agents for detoxification biogenic reactive aldehyde species (RASP), which are implicated in pathogenesis neurodegenerative disorders. show that Ir functionalized with phosphonium cations localize selectively mitochondria and have better cellular retention compared to their parent species. In a cell model Parkinsonism, mitochondria-targeted iridium catalysts exhibited superior protecting abilities longer-lasting effects (up 6 d) than conventional RASP scavengers, failed be effective beyond 24 h. Our biological assays indicate treatment compounds led reduction oxygen levels while partially preserving native mitochondrial membrane potential NAD

Language: Английский

Smartphone-based detection of levodopa in human sweat using 3D printed sensors DOI
Dalton Lee Glasco, Anjaiah Sheelam,

Nguyen H. B. Ho

et al.

Analytica Chimica Acta, Journal Year: 2023, Volume and Issue: 1273, P. 341546 - 341546

Published: June 21, 2023

Language: Английский

Citations

11

New biologicals and biomaterials in the therapy of Alzheimer's disease DOI
Vipul Prajapati, Shraddha Shinde, Princy Shrivastav

et al.

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 93 - 114

Published: Jan. 1, 2024

Language: Английский

Citations

4

A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicine DOI

Bahar Ataei,

Mahsa Hokmabadi,

Sahar Asadi

et al.

Gene, Journal Year: 2024, Volume and Issue: 912, P. 148368 - 148368

Published: March 12, 2024

Language: Английский

Citations

4

Nature's Toolbox for Alzheimer's Disease: A Review on the Potential of Natural Products as Alzheimer's Disease Drugs DOI
Nur Intan Saidaah Mohamed Yusof, Fazlin Mohd Fauzi

Neurochemistry International, Journal Year: 2024, Volume and Issue: 176, P. 105738 - 105738

Published: April 12, 2024

Language: Английский

Citations

4

Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis DOI

Rahul D. Jana,

Hieu D. Nguyen,

Guangjie Yan

et al.

Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 3, 2025

We report the application of organoiridium complexes as catalytic agents for detoxification biogenic reactive aldehyde species (RASP), which are implicated in pathogenesis neurodegenerative disorders. show that Ir functionalized with phosphonium cations localize selectively mitochondria and have better cellular retention compared to their parent species. In a cell model Parkinsonism, mitochondria-targeted iridium catalysts exhibited superior protecting abilities longer-lasting effects (up 6 d) than conventional RASP scavengers, failed be effective beyond 24 h. Our biological assays indicate treatment compounds led reduction oxygen levels while partially preserving native mitochondrial membrane potential NAD

Language: Английский

Citations

0